e-learning
resources
Munich 2014
Tuesday, 09.09.2014
New mechanisms in the pathogenesis of asthma and other lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up
S. Pospelova, S. Sobchenko, V. Kravtsov (Saint-Petersburg, Russian Federation)
Source:
International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Session:
New mechanisms in the pathogenesis of asthma and other lung diseases
Session type:
Thematic Poster Session
Number:
3866
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pospelova, S. Sobchenko, V. Kravtsov (Saint-Petersburg, Russian Federation). Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up. Eur Respir J 2014; 44: Suppl. 58, 3866
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Blockade of TSLP pathway alters asthma biomarkers
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014
The effect of budesonide on TLR expression in alveolar macrophages from smokers
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Plasma cytokine levels in non-smoking and smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
The airway microbiota is significantly altered in subjects with eosinophilic asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Activin –A and follistatin in sputum supernatant and BAL in patients with asthma
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
M2 macrophage marker CD163, CD204 and CD206 expression on alveolar macrophages in the lung of patients with chronic obstructive pulmonary
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Source: International Congress 2014 – Airway biomarkers
Year: 2014
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Disturbed pulmonary immunity and the phenotype of alveolar macrophages in bronchial asthma, gastroesophageal reflux disease and their combination
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept